This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
If you’re among the more than 350 million people across the globe who suffer from depression, then you understand how it can impact your ability to fully enjoy life. Thankfully, therapy and sometimes medication can help. However, for some depression sufferers, particularly those with clinical depression, treatment is more difficult. It can sometimes be hard to find the right combination of tools to help alleviate symptoms.
Because it can be such a struggle, a treatment called Deep Transcranial Magnetic Stimulation (Deep TMS) was developed. It may help some patients with clinical depression who have not responded to other treatments. This technique has been used at Harvard Medical School affiliate McLean Hospital, New York’s Mount Sinai Hospital, and the U.S. Navy. The Cheat Sheet spoke with Dr. Aron Tendler, Chief Medical Officer of Brainsway®, and a patient who has used Deep TMS, to learn more about this treatment. Here’s what they had to say.
Read the rest here.